Key facts
| Price (PPV) | 209 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | cefditoren |
| Class | Antibacterials for systemic use |
| ATC code | J01DD16 |
| Manufacturer | ZENITH PHARMA |
| Presentation | Boite de 20 |
| Nature | Médicament |
| Hospital price | 130.90 MAD |
| Data collected on | 9/8/2026 |
Indications
Exacerbation Bactérienne aiguë de bronchite chronique causée par Haemophilus influenzae , Haemophilus parainfluenzæ, Streptococcus pneumoniae ou Moraxella catarrhalis (y compris les ß-lactamase- Pneumonie communautaire causée par Haemophilus influenzae, Haemophilus parainfluenzæ , Streptococcus pneumoniae ou Moraxella catarrhalis . Pharyngite / amygdalite causée par Streptococcus pyogenes. Infections cutanées et sous-cutanées non compliquées causées par Staphylococcus aureus , Streptococcus pyogenes
Find an open pharmacy
On-call pharmacies near you
About Meiact 200 mg
Meiact 200 mg belongs to the antibacterials for systemic use therapeutic class. In Morocco, this drug is marketed by ZENITH PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Meiact 200 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Meiact 200 mg
Answers to common questions from Moroccan patients about this drug.